skip to Main Content

Multidisciplinary Care Is Paramount as New Therapies Emerge in Metastatic Pancreatic Cance

Newsfeed image, light gray text on dark gray background
Although the standard-of-care treatment for patients with metastatic pancreatic cancer remains largely unchanged with multi-agent chemotherapy, the role for multidisciplinary care has expanded significantly in recent years, said Andrew E. Hendifar, MD, who added that such an approach to treatment can improve quality of life, alleviate cancer-related complications, and lead to the discovery of relevant genetic predispositions.

“The treatment of [patients with] advanced pancreas cancer, fortunately, is very straightforward. We’ve made some progress; however, when we use multi-agent chemotherapy regimens, some people feel that [we haven’t made] that much progress,” said Hendifar. Read more . . . 

Back To Top